Risedronate Preserves Bone Architecture in Early Postmenopausal Women In 1 Year as Measured by Three-Dimensional Microcomputed Tomography

@article{Dufresne2002RisedronatePB,
  title={Risedronate Preserves Bone Architecture in Early Postmenopausal Women In 1 Year as Measured by Three-Dimensional Microcomputed Tomography},
  author={Thomas E. Dufresne and Paula A Chmielewski and Michael D. Manhart and Troy D. Johnson and Babul Borah},
  journal={Calcified Tissue International},
  year={2002},
  volume={73},
  pages={423-432}
}
Risedronate reduces the risk of vertebral fractures by up to 70% within the first year of treatment. Increases in bone mineral density or decreases in bone turnover markers explain only a portion of the anti-fracture effect, suggesting that other factors, such as changes in trabecular bone architecture, also play a role. Our objective was to determine the… CONTINUE READING